ARK Genomic Revolution ETF

ARKG | AMEX | 0 Followers
$24.14 +2.37% $0.56
Follow
Loading...

Profile

The ARK Genomic Revolution ETF is a thematic exchange-traded fund focused on companies involved in the development and application of innovative technologies in genomics and biotechnology. This includes firms operating in areas such as DNA sequencing, gene therapy, bioinformatics, molecular diagnostics, and personalized medicine. The ETF is actively managed by ARK Invest under the leadership of Cathie Wood, aiming to identify breakthrough technologies and high-growth companies with strong innovation potential. It is suitable for investors seeking long-term growth in the biotechnology sector, though it comes with higher volatility and risk.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade